Showing results (311-320 of 321) with videos related to
Sort By:
Pageof 33
The Plant Journal : for Cell and Molecular Biology|May 27, 2016
The genome of black raspberry (Rubus occidentalis)Robert VanBuren, Doug Bryant, Jill M Bushakra, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 8, 1999
Nuclear data for radiotherapy: presentation of a new ICRU report and IAEA initiativesM B Chadwick, D T Jones, H H Barschall, et al.Molecular Cancer Therapeutics|July 5, 2006
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeuticsKristen A Kellar, Matthew V Lorenzi, Ching Ping Ho, et al.Medical Physics|August 7, 1999
A consistent set of neutron kerma coefficients from thermal to 150 MeV for biologically important materialsM B Chadwick, H H Barschall, R S Caswell, et al.British Journal of Anaesthesia|July 25, 2020
A restrictive versus liberal transfusion strategy to prevent myocardial injury in patients undergoing surgery for fractured neck of femur: a feasibility randomised trial (RESULT-NOF)Michael A Gillies, Sadia Ghaffar, Iain K Moppett, et al.Journal of Medicinal Chemistry|May 9, 1998
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulatorsT A Grese, L D Pennington, J P Sluka, et al.American Journal of Clinical and Experimental Urology|December 27, 2023
Role of adenosine deaminase in prostate cancer progressionChristy Charles, Stacy M Lloyd, Danthasinghe Waduge Badrajee Piyarathna, et al.Indian Heart Journal|March 5, 2025
Feasibility and outcomes of PCI with novel tapered coronary stent in people living with HIV: A prospective, single-center study with literature reviewH S Natraj Setty, B H Natesh, M C Yeriswamy, et al.Journal of Medicinal Chemistry|January 17, 1997
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifeneT A Grese, S Cho, D R Finley, et al.Cancer Research|May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptorJoan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.Pageof 33